Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Revive Therapeutics Ltd.
C.RVV
Alternate Symbol(s):
RVVTF
Healthcare
Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics for rare disorders and infectious diseases. The Company is exploring the use of Bucillamine for the treatment of infectious diseases, with an initial focus on severe influenza and COVID-19. Through its subsidiary, Psilocin Pharma Corp., the Company is...
advancing the development of Psilocybin-based therapeutics in various diseases and disorders. The Company’s cannabinoid pharmaceutical portfolio focuses on rare inflammatory diseases and the Company was granted Food and Drug Administration (FDA) orphan drug status designation for the use of Cannabidiol (CBD) to treat autoimmune hepatitis (liver disease) and to treat ischemia and reperfusion injury from organ transplantation.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Company Website
Add To Watchlist
Bullboard (CSE:RVV)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(19)
•••
newonthestreet
X
View Profile
View Bullboard History
Post by
newonthestreet
on Nov 06, 2022 11:39am
Everyone
Sayin RVV more than a one trick pony. I just wanna see one trick already!!
(2)
•••
CoolioG
X
View Profile
View Bullboard History
Comment by
CoolioG
on Nov 02, 2022 11:47am
RE:Fda loves to waste Canucks time
Bunka bunka bunka......so this is where the dregs of the i-sigh crowd went....shrooms and dope LMAO
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA
posted Apr 25, 2024 9:00am by
Indiva Ltd
-
|
“Net Income was just shy of break-even in Q4, which is a testament to the popularity of our products, our industry leading low-cost production platform, and our focus on cost control. Our core brands, namely Pearls by Grön, No Future, Bhang Chocolate and Indiva Blips continue to gain market share in Canada, as Indiva continues to hold the #1 market share position in edibles nationally," said ...read more
(20)
•••
Hammer1
X
View Profile
View Bullboard History
Comment by
Hammer1
on Nov 02, 2022 8:50am
RE:Hopefully this week!
The updates move the needle for a day or two..... Then down she goes. Most people watch their investments go up and down and never pull the trigger or the chute for years. I
...more
(36)
•••
WeedKing81
X
View Profile
View Bullboard History
Post by
WeedKing81
on Oct 31, 2022 11:33am
Hopefully this week!
Excited to hear the next news updates!
(36)
•••
WeedKing81
X
View Profile
View Bullboard History
Post by
WeedKing81
on Oct 31, 2022 11:32am
Hopefully this week!
Excited to here the next news updates!
(8)
•••
RockThunder
X
View Profile
View Bullboard History
Comment by
RockThunder
on Oct 31, 2022 10:58am
RE:RE:$RVV - Updated ClinicalTrials.gov
Nothing new, we are just waiting and waiting,,its is just a coin flip and never forget it is and still a penny stock.
(31)
•••
TheTerminator1
X
View Profile
View Bullboard History
Comment by
TheTerminator1
on Oct 29, 2022 9:13am
RE:$RVV - Updated ClinicalTrials.gov
What's new???
(42)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Oct 29, 2022 7:49am
$RVV - Updated ClinicalTrials.gov
#Bucillamine https://clinicaltrials.gov/ct2/show/NCT04504734
(47)
•••
Trippedstocks
X
View Profile
View Bullboard History
Comment by
Trippedstocks
on Oct 24, 2022 12:17pm
RE:RE:RE:The end is near - Interesting Reddit post & comments !
exactly! Blind trust in a social media post. The kids are calling those things "burner accounts". Where pathetic members have a secondary profile to try to convince people that someone
...more
(163)
•••
MyAli4s
X
View Profile
View Bullboard History
Comment by
MyAli4s
on Oct 21, 2022 6:37pm
RE:RE:RE:RE:The end is near - Interesting Reddit post & comments !
Just stop pumping with BS and read:
(42)
•••
cool888
X
View Profile
View Bullboard History
Comment by
cool888
on Oct 19, 2022 7:44pm
RE:RE:RE:The end is near - Interesting Reddit post & comments !
What's your point my dear friend?
(5)
•••
1ottrunner
X
View Profile
View Bullboard History
Comment by
1ottrunner
on Oct 19, 2022 7:04pm
RE:RE:The end is near - Interesting Reddit post & comments !
Yes, some Doc with a specialty practice 20+ years in, also known as ready to retire anytime in great comfort, has piled a bunch of their money into penny biotechs and has time to post on Reddit.
...more
(31)
•••
TheTerminator1
X
View Profile
View Bullboard History
Comment by
TheTerminator1
on Oct 19, 2022 6:11pm
RE:The end is near - Interesting Reddit post & comments !
Good thing!!!
(42)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Oct 19, 2022 5:08pm
The end is near - Interesting Reddit post & comments !
#Bucillamine https://www.reddit.com/r/RVVTF/comments/y87v71/the_end_is_near/
(163)
•••
MyAli4s
X
View Profile
View Bullboard History
Comment by
MyAli4s
on Oct 19, 2022 9:49am
RE:RE:RE:We need this
Call me gravity!
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Stage Set for Creation of a Leading Intermediate Gold Producer
Centurion Identifies High Quality Gold Target-Casa Berardi West Project; Acquires Additional Claims
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study
Discover a Green Resources Stock Scoring Record Quarterly Growth
Two New Contracts Awarded Covering Five Onshore Fields Producing 3,000 bbl/d of Oil